Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inflammation and atherosclerosis.

Göran K Hansson1, Anna-Karin L Robertson, Cecilia Söderberg-Nauclér

  • 1Department of Medicine, Center for Molecular Medicine, Karolinska Institute, Stockholm SE-17176, Sweden. Goran.Hansson@ki.se

Annual Review of Pathology
|November 28, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Valganciclovir Therapy Prevents Human Cytomegalovirus Reactivation in Glioblastoma Patients Undergoing Radiochemotherapy and Extends Time to Tumor Progression.

Cancers·2026
Same author

NOD1 ligand FK565 promotes atherogenesis and accumulation of NOD1<sup>+</sup> smooth muscle cells in atherosclerotic lesions.

Atherosclerosis·2026
Same author

Human cytomegalovirus infection and cognitive decline: insights from population and experimental studies.

Frontiers in aging neuroscience·2026
Same author

Does human cytomegalovirus provide a novel therapeutic target for patients with glioblastoma?

Philosophical transactions of the Royal Society of London. Series B, Biological sciences·2025
Same author

High activity of human cytomegalovirus in patients with Sjögren's disease.

Clinical immunology (Orlando, Fla.)·2025
Same author

PCSK6 ablation in blood circulating cells increases atherosclerotic burden, but improves plaque stability by activating Th17-smooth muscle cell modulatory axis.

Vascular pharmacology·2025
Same journal

Basic Microglial Functions and How They Go Awry in Neurodegenerative Disease.

Annual review of pathology·2026
Same journal

Integration and Intersection of Cancer Metabolism with Epigenetic Pathways in Gliomas.

Annual review of pathology·2025
Same journal

The Role of Fibroblasts Across Inflammation and Immunity.

Annual review of pathology·2025
Same journal

The Role of MicroRNAs in Viral and Bacterial Infections.

Annual review of pathology·2025
Same journal

Role of Immune Cells in Hepatitis B Virus and Associated Sequelae.

Annual review of pathology·2025
Same journal

Pathology of the Coronary Arteries and Myocardium in Kawasaki Disease.

Annual review of pathology·2025
See all related articles

Atherosclerosis is an inflammatory disease driven by cholesterol buildup, leading to plaque formation and potentially heart attack or stroke. Understanding this inflammatory process is key to developing effective anti-inflammatory therapies.

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Pathology

Background:

  • Atherosclerosis is a major cause of myocardial infarction, stroke, and ischemic gangrene.
  • The disease is characterized by inflammation within the arterial wall.

Purpose of the Study:

  • To elucidate the inflammatory mechanisms underlying atherosclerosis.
  • To highlight the role of lipoproteins, immune cells, and signaling pathways in disease progression.

Main Methods:

  • Review of the molecular and cellular events initiating and perpetuating atherosclerotic plaque development.
  • Focus on the roles of low-density lipoproteins, macrophages, and T cells.

Main Results:

  • Low-density lipoprotein accumulation activates endothelial cells, promoting leukocyte recruitment.

Related Experiment Videos

  • Monocytes differentiate into macrophages, internalizing lipids to form foam cells.
  • Toll-like receptors and T helper-1 responses drive inflammation via cytokine release.
  • Plaque rupture and thrombus formation result from intensified inflammatory activation.

    • Conclusions:

    • Atherosclerosis is fundamentally an inflammatory disease.
    • Inflammatory markers can monitor disease progression.
    • Anti-inflammatory therapies show potential for managing atherosclerotic disease activity.